Related Experiment Video

Updated: Aug 13, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Scleroderma heart disease

B Marasini1, M Massarotti, R Cossutta

  • 1Rheumatology Unit, Humanitas Clinical Institute, University of Milan, Italy. bianca.marasini@humantias.it

International Journal of Immunopathology and Pharmacology
|January 4, 2006
PubMed

Insights

Systemic sclerosis can cause severe heart disease, particularly cardiomyopathy with diastolic dysfunction and arrhythmias, leading to a poor prognosis. Early detection via coronary microcirculation dysfunction is key for managing this often asymptomatic condition.

Area of Science:

  • Cardiology
  • Rheumatology
  • Internal Medicine

Background:

  • Heart disease is a common and severe complication of systemic sclerosis (scleroderma).
  • Cardiomyopathy, characterized by ventricular diastolic dysfunction and arrhythmias, significantly worsens prognosis in scleroderma patients.
  • Identifying at-risk individuals and defining the pattern of cardiac involvement remains challenging due to difficulties in in vivo evaluation.

Purpose of the Study:

  • To provide an updated review of the clinical aspects of scleroderma heart disease.
  • To highlight the critical role of coronary microcirculation dysfunction in the early development of cardiac complications.
  • To discuss available diagnostic tools for this often asymptomatic condition and review current treatment strategies.

Main Methods:

  • Literature review focusing on clinical aspects, pathophysiology, diagnostics, and therapeutics of scleroderma heart disease.
  • Analysis of studies examining coronary microcirculation dysfunction in systemic sclerosis.
  • Evaluation of diagnostic modalities and treatment options for cardiac involvement in scleroderma.

Main Results:

  • Coronary microcirculation dysfunction is an early and pivotal factor in the development of scleroderma heart disease.
  • Diagnostic tools are available to assess cardiac involvement, even in asymptomatic patients.
  • Current treatment for scleroderma-related diastolic dysfunction is unsatisfactory, and no cure for systemic sclerosis exists.

Conclusions:

  • Scleroderma heart disease, especially cardiomyopathy, poses a significant threat with a poor prognosis.
  • Early identification of coronary microcirculation dysfunction is crucial for risk stratification and management.
  • Further research is needed to improve diagnostic accuracy and develop effective therapies for this condition.

More Related Videos

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...